Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Funding
Sign In Sign Up
Night Mode
What Are the Key Challenges Facing the AAV Vector-based Gene Therapy Market?
Despite its promise, the AAV vector-based gene therapy market faces significant challenges. High treatment costs—often exceeding millions of dollars per patient—raise access and reimbursement concerns. Payers are scrutinizing value, and outcomes-based payment models are being explored. The adeno-associated virus vector-based gene therapy market also faces immunogenicity issues....
0 Comments ·0 Shares ·130 Views ·0 Reviews
Please log in to like, share and comment!